Experiencing this pandemic as a young adult has been an eye-opening experience. The virus came at a time when many young adults were supposed to be branching out and beginning their lives, but a necessary time of quarantine derailed those plans. For many of my peers, this experience brought anxiety and mental health struggles.
Thankfully, the vaccines presented a light at the end of the tunnel. After a year of isolation, young adults can step back into the workforce and resume their lives. Without medication innovation, none of this would have been possible.
Having said this, I am concerned about policies that would allow for government price-setting of medications. With the threat of the delta variant looming, now is not the time to loosen our grip on research and development.
COVID-19 serves as a lesson that we always need to be prioritizing medical innovation. I am thankful that the vaccines have provided a solution to the pandemic for the many young adults that have struggled this past year. I hope lawmakers understand the importance of medical innovation and oppose price-setting policies.